Neuromodulation of Inflammation and Endothelial Function
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 158 participants.
Also called NCT05230732
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 158 participants
- Registry
-
NCT05230732
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05230732. Randomized; quadruple masking; primary purpose treatment. Start 2022-09-01 (actual); primary completion 2027-02-27 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neuromodulation of Inflammation and Endothelial Function
- Condition
- Systolic Heart Failure
- Intervention (Device)
- neuromodulation device
- Intervention (Device)
- SHAM
- Lead sponsor
- University of Oklahoma
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct05230732- Content hash
01368ba3b4a65701326709fee3975d707b752d86f39b90ceea5ccfcd245845ab